Koya Medical Opens New Dallas HQ to Power Next Phase of Growth in Vascular Health

DALLAS, June 10, 2025 /PRNewswire/ -- Koya Medical ("Koya"), a global leader in vascular health innovation, today announced the grand opening of its new 35,000-square-foot headquarters in Dallas, Texas. This state-of-the-art facility becomes the new nerve center for Koya's manufacturing and business operations as the company rapidly scales to meet rising demand for its breakthrough therapies targeting venous and lymphatic diseases.

The new headquarters marks a major milestone for Koya, driven by strong revenue growth and increasing market traction. Koya will continue to operate its R&D hub in Silicon Valley, while shifting its core operations to Dallas.

"Opening our Dallas headquarters is a defining moment for Koya," said Andy Doraiswamy, CEO and founder. "This move enhances our ability to deliver transformative solutions that empower people living with vascular conditions. Dallas offers the talent, infrastructure, and healthcare ecosystem we need to continue to innovate and grow."

Founded in 2018, Koya is on a mission to elevate care for the millions living with venous and lymphatic conditions. Its flagship solution, Dayspring^®, is the first non-pneumatic wearable compression treatment for chronic edema—combining mobility, adherence, and clinical outcomes in a user-friendly design. Compared to legacy pneumatic compression devices, Dayspring is advancing what's possible in home-based treatment.

Koya's expanding pipeline is redefining comprehensive vascular care—from at-home management to advanced hospital interventions.

About Koya Medical
Headquartered in Dallas and founded in 2018, Koya Medical is reimagining solutions for vascular health with innovative, patient-centered offerings that support care from clinic to home. Inspired by a personal journey with post-cancer lymphedema, Koya's mission is to close treatment gaps and improve lives—starting with its FDA-cleared Dayspring system and continuing through its expanding innovation pipeline.

Why Vascular Health Matters
Over 35 million Americans live with venous and lymphatic conditions like lymphedema, chronic venous insufficiency, and deep vein thrombosis—conditions that often go underdiagnosed and undertreated. These diseases significantly impact mobility, comfort, and quality of life, and can lead to serious complications. There is an ever growing need to access modern, evidence-based therapies, essential for effective management and better patient outcomes.

To learn more, visit www.koyamedical.com and follow us on LinkedIn.

SOURCE Koya Medical